Summary. Electromyographic (EMG) activity of the uterus was recorded in vivo in 4 conscious ovariectomized ewes treated with oestrogen (one injection of 100 wg of oestradiol benzoate). Doses of 500 wg of purified porcine relaxin were injected intravenously 12, 16, 20, 24, 28 and 32 hrs after oestrogen treatment. Relaxin had an inhibitory effect on uterine activity between 16 and 32 hrs after oestrogen treatment. Because the period during which relaxin had a biological effect corresponded to the moment when oestrogeninduced uterine activity was maximal, it is suggested that the ability of relaxin to inhibit uterine activity in the ewe is oestrogen-dependent.
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Introduction.
Relaxin is a polypeptide hormone which inhibits uterine activity in a number of species (Schwabe et al., 1978) , principally guinea-pig (Porter, 1972) and rat (Porter et al., 1979 ; Cheah and Sherwood, 19811 . It has been demonstrated in rat that the biological effects of relaxin can be obtained in ovariectomized animals without oestrogen-priming (Porter et al., 1979 ; Cheah and Sherwood, 1981) but that the inhibition by relaxin of oxytocin or prostaglandin F 2a driven myometrial activity is oestrogen-dependent (Porter et al., 1981a) . Porter et al. (1981b) studying ovariectomized ewe, have shown that relaxin inhibits myometrial activity, but the effect of oestrogen priming remains unsolved since the oestrogen treatment given to all the ewes ceased 48 hrs before relaxin injection. The present experiment was carried out to study the effects of oestrogen priming on response to relaxin treatment in the ewe. The experimental design we used has already been described (Rousseau and Prud'homme, 1974) : an oestrogen injection given to ovariectomized ewe induces oestrus and uterine rhythmic electromyographic (EMG) (1974) . The contents of tubes containing biologically active relaxin (determined by mouse pubic symphysis bioassay) were pooled to form three relaxin preparations, CMB, CMa and CMa'. Since there were no apparent differences in the biological activity of these preparations (biological activity : 2 700 U/mg) (Picaper etal., 1979) , we used a composite of them. 500 !g of purified relaxin dissolved in 1 ml of physiological saline was injected into the jugular vein of each ewe 12, 16, 20, 24, 28 and 32 hrs after oestrogen administration.
Uterine EMG activity was recorded continuously in conscious animals on a pen recorder (Beckman) for 11 to 34 hrs after oestrogen injection. The EMG recordings were analyzed in 10-min periods to calculate burst frequency. The data were analyzed using Student's paired t-test.
Results.
Twelve hours after oestrogen treatment, the rhythmic EMG activity of the uterus was composed of bursts of action potentials. The mean ± SEM was 20.0 ± 2.9 bursts per min. Burst frequency increased with time, its maximum occurring between 16 and 24 hrs after oestrogen treatment in the different ewes. The mean frequency obtained at 20 hrs (28.5 ± 5.1 bursts per 10 min) was maximal, being significantly higher than the mean frequency at 12 hrs after oestrogen treatment (p < 0.05). The frequency then decreased.
Uterine activity did not change after intravenous injection of 1 ml of physiological saline.
The effect of relaxin varied with time ( fig. 11 Although the ewes received several injections of relaxin, the reduced response at 28 and 32 hrs cannot be attributed to refractiveness of the uterus after repeated injections of relaxin since the response increased from the 1st to the 3rd injection, and the decline in response appeared only after the 3rd or 4th injection.
The change in the inhibitory effect of relaxin with time and the fact that the biological effect of relaxin appeared when oestrogen-induced uterine activity was maximal, suggests that the ability of porcine relaxin to inhibit in vivo uterine activity in ovariectomized ewe is oestrogen-dependent. These data further indicate that the strongest inhibition due to relaxin was associated with the highest increase in uterine activity after oestrogen treatment ; this permits us to suppose that myometrial sensitivity to relaxin increased owing to the action of oestrogen. This increase could be a result of variations in myometrial relaxin receptors since the number of receptors in sow (Bryant-Greenwood et al., 1981) and rat (Mercado-Simmen et al., 1982) 
